Founded in 2003 and based in London, Kingsbridge Capital focuses on acquiring, managing, restructuring, and disposing of private equity transactions. With a track record of investing €750 million in four companies since 2005, the firm has had two successful exits. Kingsbridge Capital primarily invests in rounds with three participants and has a preference for startups aged 6-10 years. Their popular portfolio includes companies like Tercica, Kosan Biosciences, and Soligenix in industries such as textiles and pharmaceuticals. While the firm is based in the UK, its most frequent investments are in the United States. Kingsbridge Capital is known for its above-average lead investments and higher exit commitment compared to other organizations in the industry.